Home  >  News
News
  Zydus receives US FDA marketing nod for amlodipine & olmesartan medoxomil tablets,   September 25, 2017
  Metastatic Merkel cell carcinoma drug Bavencio receives European marketing approval,   September 23, 2017
  Zydus receives US FDA marketing nod for desoximetasone ointment & labetalol HCl tablets,   September 21, 2017
  Thrombogenics regains global rights to Jetrea from Alcon,   September 19, 2017
  Mylan launches generic Minastrin 24 FE tablets for women to prevent pregnancy in US market,   September 16, 2017
  EMA committee recommends approval of once-daily single inhaler triple therapy, Trelegy Ellipta to treat patients with COPD,   September 16, 2017
  Mitsubishi, Daiichi Sankyo introduce Canalia combination tablets,   September 09, 2017
  NuVasive receives FDA 510(k) clearance for redesigned MAGEC system with RELINE Small Stature,   September 08, 2017
  Neos Therapeutics introduces Cotempla XR-ODT ER tablets to treat ADHD in patients 6 to 17 years old,   September 07, 2017
  Ascend Therapeutics begins promotion of Sprix nasal spray,   September 06, 2017
  Dr. Reddy's Labs launches generic Skelaxin and Wellbutrin XL tablets in US market,   September 06, 2017
  Hospira recalls one lot of vancomycin HCl for injection, USP, 750 mg/vial due to presence of particulate matter,   September 04, 2017
  Mid Valley Pharma recalls Doctor Manzanilla cough & cold and allergy & decongestant relief syrup due to potential contamination,   September 02, 2017
  Amgen's Mimpara receives European marketing approval to treat secondary HPT in children with ESRD,   September 02, 2017
  Ajanta Pharma introduces generic Relpax tablets in US market,   August 31, 2017
  Daiichi Sankyo introduces oxycodone tablets "Daiichi Sankyo" for cancer pain in Japan,   August 29, 2017
  Dr Reddy's Labs launches generic Suprax in US market,   August 28, 2017
  STADA Pharma, BioQ Pharma ink agreement to commercialize 3 ready-to-use infusion products,   August 26, 2017
  Centurion Labs recalls Ninjacof & Ninjacof A products due to potential Burkholderia cepacia contamination,   August 26, 2017
  Otsuka grants license to Mylan to market MDR-TB drug Deltyba in India South Africa,   August 24, 2017

 Back
 
IPJPI_150x60en_2017
CPhI-WWW-150x60-stat-v1
IndiaLExpo
chemspec2017
www.et-whw
 
 
 
 
Copyright © 2016 Saffron Media Pvt. Ltd |